Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Natural products inhibit LPS-induced activation of pro-inflammatory cytokines in peripheral blood mononuclear cells.

Shah VO, Ferguson JE, Hunsaker LA, Deck LM, Vander Jagt DL.

Nat Prod Res. 2010 Jul;24(12):1177-88. doi: 10.1080/14786410903112680.

PMID:
20582811
2.

Inhibition of nuclear factor kappaB activation and cyclooxygenase-2 expression by aqueous extracts of Hispanic medicinal herbs.

Orlando RA, Gonzales AM, Hunsaker LA, Franco CR, Royer RE, Vander Jagt DL, Vander Jagt DJ.

J Med Food. 2010 Aug;13(4):888-95. doi: 10.1089/jmf.2009.1128.

3.

Substituted trans-stilbenes can inhibit or enhance the TPA-induced up-regulation of activator protein-1.

Deck LM, Hunsaker LA, Gonzales AM, Orlando RA, Vander Jagt DL.

BMC Pharmacol. 2008 Nov 10;8:19. doi: 10.1186/1471-2210-8-19.

4.

Efficient calculation of molecular properties from simulation using kernel molecular dynamics.

Brown WM, Sasson A, Bellew DR, Hunsaker LA, Martin S, Leitao A, Deck LM, Vander Jagt DL, Oprea TI.

J Chem Inf Model. 2008 Aug;48(8):1626-37. doi: 10.1021/ci8001233. Epub 2008 Aug 2.

PMID:
18672870
5.

Isocoumarin-based inhibitors of pancreatic cholesterol esterase.

Heynekamp JJ, Hunsaker LA, Vander Jagt TA, Royer RE, Deck LM, Vander Jagt DL.

Bioorg Med Chem. 2008 May 1;16(9):5285-94. doi: 10.1016/j.bmc.2008.03.016. Epub 2008 Mar 6.

6.
7.

TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin.

Weber WM, Hunsaker LA, Gonzales AM, Heynekamp JJ, Orlando RA, Deck LM, Vander Jagt DL.

Biochem Pharmacol. 2006 Oct 16;72(8):928-40. Epub 2006 Aug 28.

PMID:
16934760
8.

Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator.

Heynekamp JJ, Hunsaker LA, Vander Jagt TA, Deck LM, Vander Jagt DL.

BMC Chem Biol. 2006 Feb 8;6:1.

9.

Activation of NFkappaB is inhibited by curcumin and related enones.

Weber WM, Hunsaker LA, Roybal CN, Bobrovnikova-Marjon EV, Abcouwer SF, Royer RE, Deck LM, Vander Jagt DL.

Bioorg Med Chem. 2006 Apr 1;14(7):2450-61. Epub 2005 Dec 7.

PMID:
16338138
10.

Anti-oxidant activities of curcumin and related enones.

Weber WM, Hunsaker LA, Abcouwer SF, Deck LM, Vander Jagt DL.

Bioorg Med Chem. 2005 Jun 1;13(11):3811-20.

PMID:
15863007
11.

The oxidative stressor arsenite activates vascular endothelial growth factor mRNA transcription by an ATF4-dependent mechanism.

Roybal CN, Hunsaker LA, Barbash O, Vander Jagt DL, Abcouwer SF.

J Biol Chem. 2005 May 27;280(21):20331-9. Epub 2005 Mar 23.

12.

Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites.

Brown WM, Yowell CA, Hoard A, Vander Jagt TA, Hunsaker LA, Deck LM, Royer RE, Piper RC, Dame JB, Makler MT, Vander Jagt DL.

Biochemistry. 2004 May 25;43(20):6219-29.

PMID:
15147206
13.

Inhibition of pancreatic cholesterol esterase reduces cholesterol absorption in the hamster.

Heidrich JE, Contos LM, Hunsaker LA, Deck LM, Vander Jagt DL.

BMC Pharmacol. 2004 Apr 19;4:5.

14.

17-beta-Hydroxysteroid dehydrogenase type 1: computational design of active site inhibitors targeted to the Rossmann fold.

Brown WM, Metzger LE, Barlow JP, Hunsaker LA, Deck LM, Royer RE, Vander Jagt DL.

Chem Biol Interact. 2003 Feb 1;143-144:481-91.

PMID:
12604234
16.

Inhibition of yeast lipase (CRL1) and cholesterol esterase (CRL3) by 6-chloro-2-pyrones: comparison with porcine cholesterol esterase.

Stoddard Hatch M, Brown WM, Deck JA, Hunsaker LA, Deck LM, Vander Jagt DL.

Biochim Biophys Acta. 2002 Apr 29;1596(2):381-91.

PMID:
12007617
17.

The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH1 and LDH2) from Toxoplasma gondii: comparisons with pLDH from Plasmodium falciparum.

Dando C, Schroeder ER, Hunsaker LA, Deck LM, Royer RE, Zhou X, Parmley SF, Vander Jagt DL.

Mol Biochem Parasitol. 2001 Nov;118(1):23-32.

PMID:
11704270
18.

Oxidative stress indices in IDDM subjects with and without long-term diabetic complications.

VanderJagt DJ, Harrison JM, Ratliff DM, Hunsaker LA, Vander Jagt DL.

Clin Biochem. 2001 Jun;34(4):265-70.

PMID:
11440725
19.

Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4.

Yu Y, Deck JA, Hunsaker LA, Deck LM, Royer RE, Goldberg E, Vander Jagt DL.

Biochem Pharmacol. 2001 Jul 1;62(1):81-9.

PMID:
11377399
20.

Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: roles for glutathione in both enzymes and implications for diabetic complications.

Vander Jagt DL, Hassebrook RK, Hunsaker LA, Brown WM, Royer RE.

Chem Biol Interact. 2001 Jan 30;130-132(1-3):549-62.

PMID:
11306074
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk